CANOPY_1170x120_9-21-20

AllianceRx Walgreens Prime

AllianceRx Walgreens Prime offers digital clinical assessments

AllianceRx Walgreens Prime offers digital clinical assessments

ORLANDO, Fla. — Patients with chronic or complex conditions can better manage their care online, thanks to new digital clinical assessments available only through AllianceRx Walgreens Prime. In the wake of the global pandemic, the nation’s third largest specialty and home delivery pharmacy fast-tracked the release of these tools to simplify patients’ online experience when

Rick Miller receives NASP Distinguished Service Award

Rick Miller receives NASP Distinguished Service Award

ORLANDO, Fla. — The National Association of Specialty Pharmacy (NASP) has bestowed upon Rick Miller, vice president of clinical and professional services at AllianceRx Walgreens Prime, the Distinguished Service Award at the opening general session of its 2020 annual meeting. The Distinguished Service Award is given to the individual who has made a sustained contribution to

Inqovi now available through AllianceRx Walgreens Prime

Inqovi now available through AllianceRx Walgreens Prime

ORLANDO, Fla. — Adults with certain types of rare blood cancers can now receive their treatment in the comfort of their own home, thanks to a new medication available through a limited distribution with AllianceRx Walgreens Prime. Inqovi (decitabine and cedazuridine), manufactured by Taiho Oncology, treats adult patients with myelodysplastic syndromes (MDS) (a type of blood cancer) and

AllianceRx Walgreens Prime unveils new patented process for delivering specialty medicine

AllianceRx Walgreens Prime unveils new patented process for delivering specialty medicine

ORLANDO, Fla. — A new patented process for delivering specialty medicine will assure AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature. AllianceRx Walgreens Prime, one of the nation’s largest specialty and home delivery pharmacies, will exclusively use the patent – held by parent company Walgreens – to help increase patient safety, improve patient

AllianceRx Walgreens Prime to distribute Vyepti

AllianceRx Walgreens Prime to distribute Vyepti

ORLANDO, Fla. — Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti (eptinezumab-jjmr), is the first and only intravenous preventive treatment for migraine. Migraine is a complex and incapacitating neurological

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

ORLANDO, Fla. —A recent study of metastatic breast cancer (MBC) patients, prescribed a class of drugs that interrupt malignant cell growth, revealed high rates of adherence, low side effects and low rates of patients stopping their medication. The class of drugs is known as cyclin-dependent kinase (CDK) 4/6 inhibitors. The retrospective study was conducted by AllianceRx

AllianceRx Walgreens Prime renews sponsorship of web-based continuing education

AllianceRx Walgreens Prime renews sponsorship of web-based continuing education

ORLANDO, Fla. —  AllianceRx Walgreens Prime has renewed its sponsorship of accredited, web-based continuing education (CE) customized for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. “We are proud to

AllianceRx Walgreens Prime presents study at NASP meeting

AllianceRx Walgreens Prime presents study at NASP meeting

ORLANDO, Fla. — AllianceRx Walgreens Prime announced results from a new study analyzing data from patients prescribed interleukin-17 (IL-17) inhibitors for psoriasis. Patients reported improvements in psoriatic symptoms and demonstrated increased medication adherence after switching to one of the three IL-17 medications included in the study. The study was conducted with Walgreens, a parent company of

AllianceRx Walgreens Prime adds LDDs

AllianceRx Walgreens Prime adds LDDs

ORLANDO, Fla. — AllianceRx Walgreens Prime has announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the

AllianceRx Walgreens Prime expands offerings

AllianceRx Walgreens Prime expands offerings

ORLANDO, Fla. — AllianceRx Walgreens Prime announced additional medicines available to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs (LDDs), these specialty medicines treat certain types of multiple sclerosis (MS), Lambert-Eaton myasthenic syndrome (LEMS) and a form of non-Hodgkin’s lymphoma (NHL), among other complex conditions. Since last spring, the following

AllianceRx Walgreens Prime sponsors web-based continuing education program

AllianceRx Walgreens Prime sponsors web-based continuing education program

ORLANDO, Fla. — AllianceRx Walgreens Prime is sponsoring accredited, web-based continuing education (CE) customized specifically for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists. The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals. As part of its ongoing professional development and

Titan teams with AllianceRx Walgreens Prime

Titan teams with AllianceRx Walgreens Prime

SOUTH SAN FRANCISCO, Calif.  — Titan Pharmaceuticals announced Thursday the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan’s unique six-month maintenance treatment for opioid use disorder (OUD) in eligible patients. Titan expects the majority of Probuphine sales in the

Drugs targeting metastatic cancers, opioid addiction now available through AllianceRx Walgreens Prime

Drugs targeting metastatic cancers, opioid addiction now available through AllianceRx Walgreens Prime

ORLANDO, Fla. — AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy, can now offer new medicines to patients with certain rare, chronic and complex conditions. Known as limited distribution drugs, these hard-to-find medicines treat rare conditions such as advanced cancer of the stomach, community-acquired bacterial pneumonia (CABP), and opioid addiction, to name a

AllianceRx Walgreens Prime earns specialty pharmacy reaccreditation

AllianceRx Walgreens Prime earns specialty pharmacy reaccreditation

ORLANDO, Fla. — AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, received reaccreditation from URAC for its specialty pharmacy services. URAC is the independent leader in promoting health care quality through accreditation, certification and measurement. By achieving this status, AllianceRx Walgreens Prime has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.

1 2 3